M&A Deal Summary

RxE2 Acquires Habitu

On January 11, 2021, RxE2 acquired software company Habitu

Acquisition Highlights
  • This is RxE2’s 1st transaction in the Software sector.
  • This is RxE2’s 1st transaction in Israel.

M&A Deal Summary

Date 2021-01-11
Target Habitu
Sector Software
Buyer(s) RxE2
Deal Type Add-on Acquisition

Target

Habitu

Herzliya, Israel
Habitu is an Israeli-based technology company. Habitu focuses on people's habits and behaviors to create a KyP engine enabled by artificial intelligence, improving patient outcomes by providing real-time analyses of a more comprehensive set of patient data. Habitu was founded in 2018 and is based in Herzliya, Israel.

Search 215,130 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

RxE2

Fargo, North Dakota, United States

Category Company
Sector Life Science
DESCRIPTION

RxE2 LLC is a practice of pharmacy to clinical research. RxE2 is based in Fargo, North Dakota.


DEAL STATS #
Overall 1 of 1
Sector: Software M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Israel M&A 1 of 1
Year: 2021 M&A 1 of 1